Using blood cytokine measures to define high inflammatory biotype of schizophrenia and schizoaffective disorder

Abstract

Our results confirm that individuals with schizophrenia are more likely to have elevated levels of inflammation compared to controls. We suggest that efforts to define inflammatory status based on peripheral measures need to consider both mRNA and protein measures as each have distinct advantages and disadvantages and can yield different results.